Author's posts
Who’s Still Dying From Complications Related To Covid-19?
While Covid-19 deaths have declined over time as population-wide immunity increased, all the same there continue to be sub-populations predisposed to severe disease.
Inflation Reduction Act’s Drug Pricing Provisions May Lead To Lower Prices In Oncology
As IRA drug pricing provisions take shape, market dynamics will change in ways that will likely yield downward pressure, at least on the prices of existing cancer drugs.
A Substantial Gender Pay Gap In Healthcare Persists
Worldwide women still face a 24% salary gap compared to men across the healthcare sector. This figure hasn’t budged much since the early 2000s.
It’s Imperative That Public Health Messaging Improves To Counter Vaccine Misinformation
Throughout the Covid-19 pandemic, not only has there been an abundance of misinformation about vaccines, public health officials have committed missteps in messaging.
Former President Jimmy Carter’s Decision To Opt For Hospice Care Adds To His Legacy
In what is Jimmy Carter’s final chapter in life, he’s leaving behind a lasting legacy of raising awareness for the importance and dignity of hospice care.
Inflation Reduction Act May Curb Patent Practices That Forestall Market Entry Of Biosimilars
Perhaps accelerating the timeline for biosimilar (and generic) market entry is what the IRA had in mind when it chose several long monopoly products for price negotiation
Lawsuits To Block Medicare Drug Price Negotiations Are Very Unpopular Among Voters
The IRA’s drug pricing provisions are viewed favorably by voters. Accordingly, the industry’s legal challenge to block Medicare from price negotiations is unpopular.
As Sexually Transmitted Infection Incidence Rises Globally, Public Health Now Emphasizes Treatment As Prevention Over Condoms
Public health increasingly focuses on treatment as prevention. While condoms were once integral to campaigns aimed at preventing STIs this is much less the case today.
